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ABSTRACT: Tau pathology in Alzheimer’sd i s e a s ei s
intimately linked to the deposition of proteinacious ﬁlaments,
which akin to infectious prions, have been proposed to spread
via seeded conversion. Here we use double electron−electron
resonance (DEER) spectroscopy in combination with
extensive computational analysis to show that ﬁlaments of
three- (3R) and four-repeat (4R) tau are conformationally
distinct. Distance measurements between spin labels in the
third repeat, reveal tau amyloid ﬁlaments as ensembles of
known β-strand−turn−β-strand U-turn motifs. Whereas
ﬁlaments seeded with 3R tau are structurally homogeneous, ﬁlaments seeded with 4R tau are heterogeneous, composed of at
least three distinct conformers. These ﬁndings establish a molecular basis for the seeding barrier between diﬀerent tau isoforms
and oﬀer a new powerful approach for investigating the composition and dynamics of amyloid ﬁbril ensembles.
■ INTRODUCTION
Tau ﬁlaments are the pathological hallmark of numerous
neurodegenerative diseases, including Alzheimer’sd i s e a s e ,
Pick’s disease, and progressive supranuclear palsy.
1,2 Six
diﬀerent tau isoforms are expressed in the adult human brain,
which have zero, one, or two inserts in the N-terminus and
three or four semiconserved microtubule binding repeats in the
C-terminus. Based on the latter repeats, half of the isoforms are
classiﬁed as three-repeat (3R) tau and the other half as four-
repeat (4R) tau.
3 In Alzheimer’s disease, all isoforms are
deposited into ﬁlaments.
4 In Pick’s disease and progressive
supranuclear palsy, only the 3R and 4R tau isoforms are
deposited, respectively.
5 The reasons for these diﬀerences in
deposition are unknown.
Upon aggregation of intrinsically disordered tau, the repeat
region becomes protease resistant,
6 while the ﬂanking regions
remain in a fuzzy disordered state.
7 In vitro, ﬁlament formation
is induced by the addition of negatively charged cofactors, such
as heparin.
8 Removal of the ﬂanking regions produces truncated
forms of tau that contain only the repeat region: K18 for 4R tau
and K19 for 3R tau.
9 The truncated proteins show greatly
accelerated aggregation kinetics.
9 The formation of tau
ﬁlaments is a nucleated process with an initial lag phase that
is eliminated by the addition of ﬁlament seeds.
10 This
aggregation property is very similar to that of other amyloid
ﬁbrils.
11 On the structural level, ﬁlaments of truncated
12 and
full length
13 tau are characterized by highly ordered
conformations in which β-strands run perpendicular to the
long ﬁber axis. This strand arrangement is a common feature of
all amyloid ﬁbrils,
14 including those of prion proteins.
15
However, core sizes and β-sheet interactions can vary
substantially. Even proteins with the same amino acid sequence
can populate ﬁbrils with diﬀerent conformations.
16,17 In the
case of prion proteins, it is thought that this structural
polymorphism is a major contributor to phenotypic diversity.
18
Although tauopathies are not transmissible between organisms,
new evidence indicates that tau ﬁlaments can be transferred
between cells
19,20 and spread throughout the brain.
21 In this
process, tau is recruited into the ﬁlament resulting in the
conversion of normal tau into the misfolded state.
22 A variable
U-turn-based structural core of tau ﬁlaments has been proposed
to promote cross-talk with the amyloid-β peptide, suggesting
that nonhomologous proteins can interact given the right
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23,24 Interestingly, diﬀerent isoforms of tau
are characterized by an asymmetric seeding barrier, in which
ﬁlaments of 3R tau can recruit 4R tau; however, ﬁlaments of 4R
tau cannot recruit 3R tau.
25 As the seeding barrier could explain
the preferential deposition of 4R tau in progressive supra-
nuclear palsy and other 4R tauopathies, it is important to
understand the molecular basis for this barrier. We used double
electron−electron resonance (DEER) spectroscopy
26,27 in
combination with molecular modeling as a new approach to
determine conformational diﬀerences between 3R and 4R tau
ﬁlaments. We anticipate that a similar strategy could reveal
structural diﬀerences between ﬁbrils in other amyloid systems
and aid in the understanding of species spreading and
interneuronal transmission of “infectious” conformational
diseases.
■ EXPERIMENTAL PROCEDURES
Mutagenesis. The single cysteine mutant K311C of K18 and K19,
cloned into pET-28b,
3 served as template for the generation of the
double cysteine mutants K311C/C322C, K311C/G326C, and
K311C/I328C. Mutagenesis was performed using the QuikChange
method from Stratagene/Agilent Technologies. The correctness of all
sequences was veriﬁed by DNA sequencing.
Protein Expression and Puriﬁcation. Protein expression and
puriﬁcation were performed as previously described.
3 In short, after
isopropyl-β-D-thiogalactopyranoside (IPTG)-induced overexpression,
Escherichia coli, strain BL21 (DE3), was pelleted and taken up in
resuspension buﬀer (20 mM piperazine-N,N′-bis(2-ethanesulfonic
acid) (PIPES), pH 6.5, 500 mM NaCl, 1 mM ethylenediaminetetra-
acetic acid (EDTA), 50 mM β-mercaptoethanol). The cells were
heated to 80 °C for 20 min and then sonicated on ice. The samples
were centrifuged at 15000 × g for 30 min. Heat stable tau protein was
precipitated from the supernatant by addition of ammonium sulfate
(55−60% m/V). After 1 h incubation at 25 °C, the sample was
centrifuged for 10 min at 15000 × g. The protein pellet was
resuspended in H2O (2 mM dithienothiophene (DTT)), and the
solution was sonicated for 30 s, syringe ﬁltered, and loaded onto a
cation exchange column (Mono S, GE Healthcare). Proteins were
eluted with a linear NaCl gradient (50−1000 mM NaCl, 10 mM
PIPES, pH 6.5, 2 mM DTT). Protein fractions were analyzed by
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE), and appropriate fractions were pooled and stored at −80 °C.
Samples were further puriﬁed by gel ﬁltration (Superdex 200 column,
GE Healthcare) using a Tris buﬀer for elution (20 mM Tris, pH 7.4,
100 mM NaCl, 1 mM EDTA, 1 mM DTT). Pooled protein fractions
were precipitated overnight at 4 °C by addition of a three-fold
volumetric excess of acetone (5 mM DTT). The proteins were
centrifuged (15000 × g for 10 min), redistributed into equal aliquots,
and washed with acetone (2 mM DTT). All pellets were stored at −80
°C until further use.
Protein Preparation and Labeling. Protein pellets of double
cysteine mutants were solubilized in 200 μL of 8 M guanidine
hydrochloride. An approximately 10-fold molar excess of paramagnetic
label [1-oxyl-2,2,5,5-tetramethyl-Δ3-pyrroline-3-methyl]-
methanethiosulfonate (Toronto Research Chemicals, Downsview,
Toronto) was added. Samples were incubated for 1 h at 25 °C.
Proteins were then passed over PD-10 desalting columns (GE
Healthcare) to remove denaturant and excess label. The elution buﬀer
consisted of 100 mM NaCl, 10 mM HEPES, pH 7.4, and 1 mM NaN3.
Samples of wild-type tau (K18 and K19 with cysteines replaced by
serines) were processed the same way as double cysteine mutants with
the exception that no label was added. Protein concentrations were
determined by the bicinchoninic acid (BCA) method (Pierce).
Multistep Seed Production. For initial ﬁlament formation, 25
μM of wild-type tau (in elution buﬀer) was combined with a two-fold
molar excess of heparin (average molecular mass of 5000 Da, Celsus,
Cincinnati, OH) and incubated for three days at 25 °C under agitation.
Seeds were produced by sonicating the samples for 20 s on ice at
power setting 3 using a Fisher Scientiﬁc soniﬁer (150 T Series)
equipped with a 3 mm tip. To 25 μM wild type tau and 50 μM
heparin, 10% seeds (based on monomer concentration) were added.
Fibril growth proceeded for 1 h at 37 °C.
Again, seeds were produced, and the formation of the next set of
ﬁlaments initiated. The procedure was performed a total of four times.
Seeds from the last cycle were used for DEER sample preparation. It
was assumed that multiple steps of seeding and growth would result in
homogeneous ﬁlaments. Interestingly though, polymorphic ﬁlaments
were observed even after multiple cycles of seeding (see Results
Section).
Sample Preparation for DEER Experiments. Filaments for
DEER measurements were prepared by mixing doubly spin labeled tau
mutants of K18 or K19 with a 50-fold molar excess of the
corresponding wild-type constructs (total protein concentration = 50
μM), 5% seeds from the fourth seeding cycle (above), and heparin
(protein:heparin molar ratio of 4:1). After 14 h incubation at 37 °C,
the ﬁlaments were pelleted at 100000 × g and washed once with
elution buﬀer. The ﬁnal ﬁlament pellets were taken up in 20−50 μL
elution buﬀer, transferred into quartz capillaries (1.1 mm inner
diameter × 1.6 mm outer diameter) and centrifuged for 20 min at
1000 × g. Residual buﬀer layered over the ﬁlaments was removed with
a syringe. To test for short-range spin−spin interactions, continuous
wave electron paramagnetic resonance (CW EPR) spectra were taken
at 25 °C (see Supporting Information). Subsequently, capillary tubes
were ﬂash frozen in liquid N2 and stored at −80 °C until further
measurement.
DEER Data Acquisition and Analysis. DEER data were obtained
at Q-band frequencies (34 GHz) with a Bruker Elexsys E580
spectrometer equipped with a 1 W ampliﬁer, a Bruker ER 5107 Q-
band dielectric pulse resonator, and an Oxford CF 935 cryostat.
Measurements were performed using four-pulse DEER experiment:
π/2(νobs) − τ1 − π(νobs) − t′ − π(νpump) − (τ1 + τ2 − t′) − π(νobs) −
τ2 − echo.
27 The resonator was fully overcoupled (Q ∼ 100). All
measurements were performed at a temperature of 80 K. The observer
pulse lengths π/2 and π were optimized for each measurement and
ranged from 30−40 and 60−80 ns, respectively. A pump pulse length
of 40 ns was used, and τ1 and τ2 were kept constant, while time t′ was
varied. Data analysis was performed for dipolar evolution times t = t′ −
τ1 > 0. The pump frequency, νpump, was set to the center of the
resonator dip, and the magnetic ﬁeld was set in the center of the
nitroxide EPR spectrum. The observe frequency, νobserver, was 37 MHz
higher than vpump, which is a 13 G oﬀset to lower ﬁeld.
28 The shot
repetition time was calculated for each run as 1.2 times the T1
relaxation time,
29 usually between 500 and 550 μs, and eight-step
phase cycling was used. The total measurement time for each sample
was 48−72 h. T1 values were obtained from inversion recovery curves
by ﬁtting with a single exponential to obtain an average value for the
heterogeneous ﬁlaments. These values were not signiﬁcantly diﬀerent
between constructs or mutants and were comparable to values
obtained by ﬁtting with multiexponential functions. Results were the
same for data collected with longer shot repetition times.
DEER data were analyzed using “DeerAnalysis2011”,
30 a program
that can extract distance distributions from dead-time free pulse
electron−electron double resonance (ELDOR) data (constant-time
and variable-time pulse DEER). A background correction is ﬁrst
performed to ensure that intermolecular distances are suppressed.
Only intramolecular distances are taken into account when calculating
the distance distribution in the protein. The background correction
was done using a 3D homogeneous function, and the data were ﬁt
using Tikhonov regularization with a regularization parameter, α,o f
100.
Computational Simulation and Analysis. Molecular dynamics
simulations were performed by the NAMD program
31 using the
Charmm27 force ﬁeld. The tau oligomers were energy minimized and
explicitly solvated in a TIP3P water box with a minimum distance of
15 Å from any edge of the box to any tau atom. Counterions of NaCl
were added to neutralize the systems. Both equilibrium and
production runs were performed using an NPT ensemble under
periodic boundary condition. Constant pressure (1 atm) and
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barostat with a decay period of 100 fs and a Langevin thermostat with
ad a m p i n gc o e ﬃcient of 5 ps−1. The long-range electrostatic
interactions were treated by the particle mesh Ewald (PME) method
using a real space cutoﬀ of 12 Å and a grid size of ∼1 Å in all
directions. The short-range van der Waals (vdW) interactions were
calculated using a switching function with a twin range cutoﬀ of 10 and
12 Å. The velocity Verlet integrator with a time step of 2 fs was used to
solve Newton’s equation of motion. In the MD-MC rotamer
simulations, we labeled two dihedrals: N−Cα−Cβ−Sγ for the ﬁrst
mutated residue (χ1) and the second mutated residue (χ2). Both χ1
and χ2 were rotated from 0 to 360° by 6° interval, resulting in the 60
× 60 rotamer combinations. Each of the 3600 (χ1, χ2) pair rotamers
was subjected to 3000 step energy minimization and 2000 step
molecular dynamics to obtain the fully relaxed structure. The
probability distributions of nitroxide distance in the 3600 rotamers
were calculated based on the Boltzmann energy distributions, using an
in-house MC algorithm.
32
■ RESULTS
Templated Growth Produces a New Type of 4R Tau
Filaments. DEER spectroscopy allows the determination of
distances between pairs of paramagnetic labels that are
separated by 2−5 nm.
27,29 Recent DEER experiments have
provided structural information on single amyloid ﬁbril
conformers of islet amyloid polypeptide
33 and α-synuclein.
34
Here, we set out to test whether this approach is able to
distinguish between ﬁlament conformers of 3R and 4R tau. As a
ﬁrst step, we generated the double cysteine mutants 311/322,
311/326, and 311/328 of K18 and K19. All mutations were
located in the R3, which forms a stable core with parallel, in-
register arrangement of β-strands in the ﬁlament.
3,35 All
mutants were labeled with the thiol-reactive nitroxide label
[1-oxyl-2,2,5,5-tetramethyl-Δ3-pyrroline-3-methyl] methane-
thiosulfonate. Filament formation was induced by the addition
of heparin (tau:heparin ratio of 4:1 (n:n)). CW EPR analysis of
these samples at room temperature revealed single-line spectra
(Figure S1, Supporting Information), characteristic of spin
exchange between stacked labels along the long ﬁber axis.
36
Importantly, these experiments demonstrate that double
labeling of tau in this region does not perturb the ﬁlament
core but retains the parallel, in-register arrangement of β-
strands.
To measure the interspin distances between the two labels
within individual tau molecules, intermolecular spin−spin
interactions along the ﬁber axis had to be minimized. For this
purpose all labeled proteins were mixed with their respective
“wild-type” counterparts at a 1:50 molar ratio. Speciﬁcally,
doubly labeled K18 was mixed with cysteine-free K18, and
doubly labeled K19 was mixed with cysteine-free K19. These
monomer mixtures were grown onto the seeds produced from
cysteine-free K18 or K19 ﬁlaments (see Experimental
Procedures Section). We investigated three diﬀerent seeding
schemes: (1) K18 grown on K18 seeds, (2) K19 grown on K19
seeds, and (3) K18 grown on K19 seeds. The monomers
successfully grew onto the templates in all cases. The
ﬁlamentous nature of the aggregates was veriﬁed by negative
stain electron microscopy (Figure S2, Supporting Information).
CW EPR measurements of the sedimented ﬁlaments revealed
no spectral broadening for any of the spin pairs (Figure S3,
Supporting Information), indicating the absence of signiﬁcant
populations of conformers with interspin-distances smaller than
about 2 nm. Importantly, these measurements ascertained that
double mutants did not preferentially stack upon themselves
during ﬁlament growth. As a consequence, the spin−spin
interactions detected by DEER for the diluted ﬁlaments must
be the result of intramolecular interactions.
DEER measurements were carried out at Q-band (34 GHz)
resulting in an ∼10-fold increase in sensitivity relative to
conventional X-band (9.4 GHz) measurements.
28,37,38 The
dipolar oscillation traces for each double mutant are compared
for ﬁlaments prepared by the three diﬀerent seeding schemes.
The traces for 311/322 indicate similar spin−spin interaction
for all three types of ﬁlaments (Figure 1a). Markedly, the traces
for K19-seeded ﬁlaments of K19 and K18 nearly superimpose
suggesting similar ﬁlament conformations when grown onto the
same K19 seeds. This notion is further supported by the
oscillation traces of the 311/326 and 311/328 ﬁlaments (Figure
1b,c). While the K18-seeded ﬁlaments show strong spin−spin
interactions (indicated by the rapid initial drop in intensity),
the K19-seeded ﬁlaments show only weak spin−spin
interactions (indicated by the small initial drop in intensity).
For both 311/326 and 311/328 the dipolar oscillations for K18
on K19 are similar to those for K19 and dramatically diﬀerent
than for K18. In fact, doubly labeled K19 ﬁlaments produce an
oscillation trace that is similar to that for singly labeled K19
controls (compare green and red traces in Figure 1b) implying
interspin distances above 5 nm. These longer distance
conformers are also dominant in the K19-seeded K18 ﬁlaments
for 311/326 and 311/328. However, the slightly greater drop in
the initial intensities (compare the blue with red traces)
Figure 1. Dipolar oscillation traces reveal major structural diﬀerences between K18 and K19 ﬁlaments. Filaments were grown through seeded
reactions with monomeric tau labeled at positions 311/322 (a), 311/326 (b), and 311/328 (c): K18 grown on K18 seeds (black traces), K19 grown
on K19 seeds (red traces), and K18 grown on K19 seeds (blue traces). The green trace in the center panel is from singly labeled K19 monomers
(311 and 326) grown onto K19 seeds. The dipolar traces for positions 311/326 and 311/328 indicate diﬀerent spin interactions and hence diﬀerent
structures for K18- versus K19-seeded ﬁlaments. Labeled protein: 1 μM, unlabeled protein: 50 μM, seeds: 5% (mol:mol).
Journal of the American Chemical Society Article
dx.doi.org/10.1021/ja303498q | J. Am. Chem. Soc. 2012, 134, 10271−10278 10273suggests the existence of a minor subpopulation of K18
ﬁlaments with smaller interspin distances.
In summary, our experiments reveal major structural
diﬀerences between K18 and K19 seeded ﬁlaments and provide
molecular evidence for the conformational plasticity of K18,
which assumes the conformations of its seeds.
Tau Filaments Are Heterogeneous. To determine the
interspin distances for the diﬀerently labeled K18 ﬁlaments, the
dipolar oscillation traces in Figure 1 were ﬁt by Tikhonov
regularization
39 in the time and frequency domains (Figure
2a,b). The resulting distance distributions (Figure 2c) revealed
major peaks at 3.2 and 3.8 nm for 311/322, 3.5 and 4.0 nm for
311/326, and 4.8 nm for 311/328. Additional peaks with
smaller amplitudes are observed for all three double mutants.
Analysis of dipolar oscillation curves recorded with diﬀerent
numbers of scans, and therefore diﬀering signal-to-noise, gave
consistent distance distributions. The distance distributions
shown in Figures 2 and 3 were obtained by using a
homogeneous three-dimensional function for the background
subtraction because it gave the best ﬁt to the curves for
ﬁlaments obtained from singly labeled tau. The results indicate
that the distributions of interspin distances are due to
heterogeneity of the ﬁlament conformation and conformations
of the spin label, rather than errors introduced by Tikhonov
regularization.
The oscillation traces for ﬁlaments of K19 or K18 grown on
K19 were ﬁt in an analogous manner (Figure 3a,b). The 311/
322 mutants provided meaningful distance distributions (Figure
3c). Notably, the distance distributions for 311/322 were
comparable for K19 and K18 grown on K19 (major interspin
distance of 3.5−3.7 nm), supporting the model of similar
ﬁlament conformations. For 311/326 and 311/328, the dipolar
oscillation traces for K19 or K18 grown on K19 were quite
similar to those for singly labeled mutants, which indicates that
the dominant conformers have long interspin distances (above)
that are not accessible to DEER distance determination with
the 2.4 μs data acquisition windows. The length of the data
acquisition window was limited by the short spin echo
dephasing time, Tm,o f∼1.2−1.4 μs for these samples.
Structural Insights into the Heterogeneous Folding of
Tau Filaments. Previous work has suggested that each tau
repeat is a folding unit within the ﬁlament
3,40,41 and that R3
could be categorized into at least three diﬀerent types of
conformations: (1) straight-line (SL)-shape, (2) L-shape, and
(3) U-shape (Figure 4).
41 Here, we asked whether these
modeled conformations could help in the interpretation of the
experimentally derived distance distributions.
Based on extensive molecular dynamics simulations of wild-
type K18 and K19 with explicit water solvation, the calculated
distances between the nonhydrogen terminal atoms for the
native side chains of K18 and K19 for 311/322, 311/326, and
311/328 in the SL-conformation are shown in Figure S4,
Supporting Information. The relatively narrow distance
distributions indicated that the modeled side chains are in
Figure 2. Analysis of DEER data for K18 311/322, 311/326, and 311/
328 grown onto K18 seeds reveals structurally heterogeneous
ﬁlaments. Fitting by Tikhonov regularization is shown in red on the
dipolar evolution curves after background subtraction in (a) time
domain and (b) frequency domain. (c) Distance distributions. The
broad distributions indicate coexistence of multiple conformers of K18
ﬁlaments.
Figure 3. Tau ﬁlaments seeded with K19 are structurally
homogeneous. DEER data are analyzed by Tikhonov regularization.
K19 311/322 grown on K19 seeds (upper row). K18 311/322 grown
on K19 seeds (lower row). Best ﬁts in red on background corrected
evolution curves in (a) time domain and (b) frequency domain. (c)
Distance distributions. The narrow distributions indicate a limited
number of conformers.
Figure 4. Structural models of tau ﬁlaments. The K18 models were
optimized by extensive molecular dynamics simulations and emphasize
the three basic conformations of the third repeat (blue): SL-, L-, and
U-shapes, which have also been modeled for K19 ﬁlaments.
41 The
remaining tau repeats are represented by diﬀerent colors. These
repeats can assume additional conformations.
41 However, for clarity,
those conformations are not depicted. Labeled residues (Cα) are
indicated by colored dots. Pairs of labels for which distances were
determined by DEER are labeled by arrows. Repeats 1−4 are
abbreviated as R1−R4.
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distributions. Therefore it was assumed that although the
nitroxyl side chains attached to mutated cysteines are larger
than the native side chains, the orientations of the spin labels
would be similar to the orientations of the native side chains.
For the SL-conformations, the inter-side chain distances for
311/326 and 311/328 are much longer than for 311/322.
These predictions are in qualitative agreement with the DEER
results for K19 and K18 on K19, where the conformations for
311/326 and 311/328 have nitroxyl−nitroxyl distances that are
too long for characterization by DEER of tau samples with
short phase memory times. Quantitative distance comparisons
require explicit inclusion of the labels.
The observations that nitroxyl−nitroxyl distances for K18
311/322, 311/326, and 311/328 are within the range
detectable by DEER indicate that conformations are diﬀerent
than for K19, and conformations other than SL need to be
considered. For nitroxyl spin labels the unpaired spin density is
localized predominantly on the >NO moiety, so distances
obtained by DEER are the >NO to >NO distances which are
approximated as oxygen−oxygen distances. To identify which
R3 conformer has the highest population in the K18 ﬁlaments,
we simulated the distributions of the distances between the two
nitroxyl groups in spin-labeled molecules based on the
aforementioned three models. First, three pentamers of each
model were used to represent the ﬁlament structure. For each
pentamer, double Cys mutations were made in the middle
chain at 311/322, 311/326, and 311/328, respectively, as in the
DEER experiments. The rotamer distributions of the labeled
side chain (Figure 5a) were calculated by a combined molecular
dynamics simulation and Monte Carlo method (MD-MC) and
Gunnar Jeschke’s MMM algorithm.
42 In the MMM algorithm
conformations of the spin label that ﬁt into the local peptide
structure are selected from a library of conformations observed
in X-ray crystal structures of spin-labeled proteins. As shown in
Figure 5b and Table S1, Supporting Information, the results
Figure 5. K18 ﬁlaments are composed of at least three distinct conformers. (a) Diﬀerent rotamer arrangements within the tau ﬁlament, exempliﬁed
by MD snapshots from the labeled 311/322 pair in SL-shape, contribute to the measured distance distribution in K18. The nitroxyl groups are
represented as spheres (blue: N atom, red: O atom). (b) Experimental DEER data are overlaid with simulated distance distributions for the three
basic conformers of R3: L-, SL-, and U-shapes (see Figure 4). DEER observations are represented in black, MD results in red, and MMM results in
blue. A mixture of diﬀerent ﬁlament conformers explains the DEER distance distributions. (c) Comparisons of experimental distance distributions
and simulated distributions of the mixture of three conformers (L:SL:U = 6:3:1) for 311/322 (left), 311/326 (center), and 311/328 (right). Same
color coding as in (b). The global ﬁtting reveals a minimum of 30% SL-shape structure in K18 ﬁlaments.
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The MD-MC distributions are in better agreement with the
observed DEER spectra and reveal ﬁner details for L-shape.
The distributions in the U-shape model indicate shorter
distances than the DEER observation, which suggests that the
U-shape model is not the major populated structure in K18
ﬁlaments. The major peaks in the 311/322 mutant in the L-
and SL-shapes do not show large diﬀerences, since in both L-
and SL-shape models, the residues at positions 311−322
protrude from an almost straight line (Figure 4). However,
because the environments of the L- and SL-shape models diﬀer,
the minor peaks show some signiﬁcant diﬀerences. The major
peaks in the 311/326 and 311/328 mutants present large
diﬀerences between the L- and SL-shapes. The MD-MC
calculations of the distance distributions for the L-shaped 311/
326 and 311/328 mutants almost overlap the DEER
observation for the K18 ﬁlament, while the SL-shape
distributions present distances that are slightly longer than
5.0 nm. The comparison of experimental and calculated results
suggests that K18 ﬁlaments are heterogeneous with contribu-
tions from diﬀerent conformers. K19 and K18 ﬁlaments grown
on K19 seeds by contrast are more homogeneous and
dominated by SL-shape conformations.
We then analyzed the possible population distribution of the
three ﬁlament structures in the K18 ﬁlaments by ﬁtting DEER
observation with a mixture of the three structural models (L-,
SL-, and U-shapes). The MD-MC method is more suitable for
population distribution calculation since it can be weighted
using Boltzmann energy distribution, while the MMM method
can only use a simple average value from three conformers. As
shown in Figure S5, Supporting Information, the 311/328
mutant can be well ﬁtted with the ratio of L:SL:U = 1:6:1,
indicating that the highest percentage of SL-shape structure
could be 75%. However, at this high SL-shape ratio, the ﬁttings
of the 311/322 and 311/326 mutants are less satisfactory
(Figure S5, Supporting Information), indicating that the spin-
labeled double mutants have varied preferences for diﬀerent
conformers. The global ﬁtting for the three mutants: 311/322,
311/326, and 311/328 can be obtained by a mixture of L:SL:U
= 6:3:1 (Figure 5c), suggesting at least 30% SL-shape structure.
Thus, our study indicates that the population of SL-shape
structure in heterogeneous K18 ﬁlaments could be in the range
of 30−75%. It should be noted that the structural models are
derived computationally and hence may not comprise the full
spectrum of possible structures. This could explain the reduced
number of rotamers that is observed for K19 seeded ﬁlaments
(Figure 3c) and the absence of any modulation in the 311/326
and 311/328 ﬁlaments of K19 (Figure 1b,c). Additional
experimental constraints will be necessary to gain further
structural insights. Regardless of the speciﬁc conformation, the
population analysis oﬀers a possible explanation why
homogeneous K19 ﬁlaments can seed K18 monomers, but
heterogeneous K18 ﬁlaments fail to recruit K19 monomers.
The overall height of the latter barrier might be further
modulated by sequence and conformation incompatibilities
between the two diﬀerent tau isoforms.
■ DISCUSSION
Tau ﬁlaments are characterized by an asymmetric barrier in
which monomers of 4R tau can grow onto ﬁlaments of 3R tau;
however, monomers of 3R tau cannot grow onto ﬁlaments of
4R tau.
25 Here we have used site-directed spin labeling in
conjunction with DEER spectroscopy to elucidate the
molecular basis for this cross-seeding barrier. A set of three
doubly labeled cysteine mutants (311/322, 311/326, and 311/
328) reveals large-scale conformational variations in the third
repeat of K18 (4R) and K19 (3R). Speciﬁcally, the distances
between spin labels in K19 ﬁlaments indicate a fully extended
conformation, while the distances in K18 ﬁlaments are
suggestive of bends. Importantly, when K18 monomers are
cross-seeded with K19 ﬁlaments, the newly incorporated
monomers assume the extended conformation of the seeds.
This conformation is stable over multiple cycles of seeding and
ampliﬁcation, as K18 ﬁlaments retain their ability to eﬀectively
recruit K19 monomers.
25 The distance measurements provide
compelling molecular evidence for the structural plasticity of
tau
43 as the initial seeds imprint their conformation onto the
recruited K18 monomers. The measurements further indicate
that when aggregated by themselves, K18 monomers form a
heterogeneous mixture of ﬁlaments with dominant subspecies.
Computational simulations suggest that the ratio of the bent
conformer to the fully extended conformation could be around
2:1.
Structural heterogeneity, conformation-based seeding bar-
riers, and emergence of new ﬁbril strains are important
characteristics of prions and are thought to be intimately
associated with function. Here we show that similar structural
characteristics also hold for tau. Although there is currently no
evidence linking diﬀerent tau ﬁlament conformations to
diﬀerent tauopathies, the recently observed transmission of
tau ﬁlaments between cells in tissue culture
19 and trans-synaptic
spreading of tau pathology in vivo
44,45 suggests that such
connections may exist. Insights gained from prions might serve
as viable mechanistic models for tau.
A serious challenge to the protein-only hypothesis of prion
transmission was the question of how a single protein could
account for diﬀerent strains or variants. Multiple lines of
evidence from mammalian prions have shown that distinct
conformers could encode the information for these diﬀer-
ences.
46−48 Similar conclusions were derived from the
experimentally more tractable yeast prions (which show no
sequence homology to their mammalian counterparts). The
transformation of conformationally distinct ﬁbrils of
Sup35p
49,50 and Ure2p
51 into yeast cells resulted in distinct
phenotypes that could be propagated over multiple generations.
Conformational diversity of protein ﬁbrils has also been
observed for other amyloids, such as Aβ
52 and α-synuclein,
53
although as with tau, a clear link to diﬀerent disease phenotypes
has not yet been established.
It has long been recognized that variations in amino acid
sequence between prion proteins are associated with barriers in
transmission.
54 The substitution of only one or two amino acids
can result in a robust barrier if positioned in a key region of the
protein.
55,56 Since a particular sequence can result in a
spectrum of diﬀerent ﬁbril conformers,
17,18 each conformer
will have its own seeding characteristics. As a consequence, the
seeding barrier will be determined not only by sequence but
also by conformation and conformation population distribu-
tions.
17,18 Changes in the cellular environment could aﬀect the
composition of ﬁbril conformers
57 and hence inﬂuence the
seeding barrier. It is interesting to note that in a cell-free
system, seeds of the P301L mutant of tau prevented growth of
wild-type tau,
58 while in cell culture this barrier did not exist.
22
Similarly, seeds of 3R tau incorporated 4R tau in vitro, yet in
cell culture no such incorporation was observed.
59 In contrast,
the barrier which prevents growth of 3R tau onto 4R tau seeds
Journal of the American Chemical Society Article
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that 3R tau is compatible with only a very small number of 4R
tau conformers. One such conformer emerges through the
cross-seeding of 4R tau with 3R tau seeds.
25
The emergence of new strains after the crossing of a
transmission barrier is a well-known property of prions. For
example, variant Creutzfeldt Jacob disease has been linked to
the transmission of bovine prions to humans.
60 In this process,
the human prion protein is thought to assume the
conformation of the bovine template. Convincing molecular
evidence for the emergence of new prion strains has been
presented using the prion protein variant Y145Stop.
61 A mouse
prion variant that was seeded with hamster prion ﬁbrils resulted
in a new ﬁbril type that had the capacity to seed hamster prions.
Importantly, when mouse prion ﬁbrils were formed in the
absence of hamster prion seeds, a barrier existed between the
diﬀerent proteins. The asymmetric barrier that is observed for
ﬁlaments of 3R and 4R tau and the emergence of a new 4R tau
conformer upon seeding with 3R tau resembles these prion
characteristics.
The underlying basis for these overall similarities must reside
within the shared structural properties of the amyloid fold and
conformational selections among the diﬀerent structures.
Amyloid ﬁbrils together with other cellular components provide
a non-DNA-based means for propagating information.
62 It is
tempting to speculate that the phenotypic diversity of human
tauopathies could be linked to diﬀerent conformers and that
preferential deposition of 3R tau in Pick’s disease and 4R tau in
progressive supranuclear palsy could be based on diﬀerential
seeding properties and clearance of slowly propagating strains.
If tau ﬁlaments are ensembles of conformers, the question
arises whether the composition of these ensembles could
change as the aggregates transferred between diﬀerent neurons.
The recently observed evolution of prions in cell culture
63
suggests that such diversiﬁcation is possible. With the ability to
resolve diﬀerent conformers within a heterogeneous mixture,
the herein presented DEER approach, in combination with
large scale molecular dynamics simulations, provides a new
powerful tool to investigate the composition and dynamics of
amyloid ensembles.
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